Comparison of IFN-γ responses to mycobacterial antigens as markers of response to BCG vaccination

Tuberculosis

Volumn 88, Issue 1, 2008, Pages 31-38

  Weir, Rosemary E ^a   Fine, Paul E M ^a   Floyd, Sian ^a   Stenson, Sally ^a   Stanley, Carolynne ^a   Branson, Keith ^a   Britton, Warwick J ^b   Huygen, Kris ^c   Singh, Mahavir ^d   Black, Gillian F ^a   Dockrell, Hazel M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CENTENARY INSTITUTE   (Australia)

^c PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

BCG; Interferon gamma; Mycobacterial antigens; TB vaccines; UK schoolchildren; Whole blood assay

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; HEPARIN; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; BLOOD SAMPLING; CHILD HEALTH CARE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SCHOOL CHILD; SKIN TEST; TUBERCULIN TEST; TUBERCULOSIS; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ANTIGENS, BACTERIAL; BCG VACCINE; BIOLOGICAL MARKERS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MYCOBACTERIUM; TUBERCULOSIS; VACCINATION;

EID: 37249075893     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.10.001     Document Type: Article

References (25)

1. Doherty T.M. Real world TB vaccines: clinical trials in TB-endemic regions. Vaccine 23 (2005) 2109-2114
2. Black G.F., Weir R.E., Floyd S., Bliss L., Warndorff D.K., Crampin A.C., et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359 (2002) 1393-1401
3. Orme I.M., Andersen P., and Boom W.H. T cell responses to Mycobacterium tuberculosis. J Infect Dis 167 (1993) 1481-1497
4. Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 45 (1997) 115-131
5. Orme I.M. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 24 (2006) 2-19
6. Wiker H.G., and Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56 (1992) 648-661
7. Johnson S., Brusasca P., Lyashchenko K., Spencer J.S., Wiker H.G., Bifani P., et al. Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis. Infect Immun 69 (2001) 5936-5939
8. McShane H., Pathan A.A., Sander C.R., Keating S.M., Gilbert S.C., Huygen K., et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10 (2004) 1240-1244
9. Olsen A.W., Williams A., Okkels L.M., Hatch G., and Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 72 (2004) 6148-6150
10. Ewer K., Deeks J., Alvarez L., Bryant G., Waller S., Andersen P., et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361 (2003) 1168-1173
11. Harboe M., Oettinger T., Wiker H.G., Rosenkrands I., and Andersen P. Evidence for occurence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64 (1996) 16-22
12. Weir R.E., Fine P.E., Nazareth B., Floyd S., Black G.F., King E., et al. Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol 134 (2003) 285-294
13. Department of Health. Tuberculosis: BCG immunisation. In: Salisbury D.M., and Begg N.T. (Eds). Immunisation Against Infectious Disease (1996), HMSO, London 231-232
14. Demissie A., Ravn P., Olobo J., Doherty T.M., Eguale T., Geletu M., et al. T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect Immun 67 (1999) 5967-5971
15. Ravn P., Demissie A., Eguale T., Wondwosson H., Lein D., Amoudy H., et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 179 (1999) 637-645
16. Black G.F., Weir R.E., Chaguluka S.D., Warndorff D., Crampin A.C., Mwaungulu L., et al. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Clin Diagn Lab Immunol 10 (2003) 602-611
17. Rosseels V., Marche S., Roupie V., Govaerts M., Godfroid J., Walravens K., et al. Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle. Infect Immun 74 (2006) 202-212
18. Thole J., Wieles B., Clark Curtiss J., Ottenhoff T., and de Wit T. Immunological and functional characterization of Mycobacterium leprae protein antigens: an overview. Mol Microbiol 18 (1995) 791-800
19. Horwitz M.A., and Harth G. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71 (2003) 1672-1679
20. Weir R.E., Black G.F., Nazareth B., Floyd S., Stenson S., Stanley C., et al. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi. Clin Exp Immunol 146 (2006) 390-399
21. Geluk A., Lin M.Y., van Meijgaarden K.E., Leyten E.M., Franken K.L., Ottenhoff T.H., et al. T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination. Infect Immun 75 (2007) 2914-2921
22. Lin M.Y., Geluk A., Smith S.G., Stewart A.L., Friggen A.H., Franken K.L., et al. Lack of Immune Responses to Mycobacterium tuberculosis DosR Regulon Proteins following Mycobacterium bovis BCG Vaccination. Infect Immun 75 (2007) 3523-3530
23. Triccas J.A., Winter N., Roche P.W., Gilpin A., Kendrick K.E., and Britton W.J. Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein. Infect Immun 66 (1998) 2684-2690
24. Wilkinson R.J., Haslov K., Rappuoli R., Giovannoni F., Narayanan P.R., Desai C.R., et al. Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol 35 (1997) 553-557
25. Wiker H., Nagai S., Hewinson R., Russell W., and Harboe M. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv. Scand J Immunol 43 (1996) 374-380